What Is New With Drug Injury Litigation in September 2026? Latest court filings and settlement notices and Key Takeaways

In September 2026, drug injury litigation is mostly about expert evidence hearings and tracking case counts, not new payouts. The GLP-1 and Depo-Provera cases both have expert hearings this month, Zantac claimants are being paid through private deals, and the Tepezza and Suboxone cases are still pending. None of these cases has a public claim form open right now.

A multidistrict litigation (MDL) is a group of similar federal lawsuits sent to one judge for pretrial work. It is not a class action. Each person keeps their own case, and any payment usually comes through a settlement program rather than a claim form anyone can file. That difference shapes what readers can actually do this month.

Official resources:

Read the original report from Uscourts — Use this primary source to review the complete report.
Read the official notice from Uscourts — Use this primary source to verify the official announcement.

Where Do the GLP-1 Weight-Loss Drug Lawsuits Stand?
What Is Happening in the Depo-Provera Brain Tumor Cases?
What Do the Zantac Rulings Mean for Claimants?
What About Tepezza and Suboxone?
How to Track These Cases Yourself
Frequently Asked Questions

Where Do the GLP-1 Weight-Loss Drug Lawsuits Stand?

MDL 3094 in the Eastern District of Pennsylvania is before Judge Karen S. Marston. It combines claims that GLP-1 drugs caused gastroparesis (stomach paralysis), ileus, or intestinal blockage. According to the federal court's MDL 3094 page, it holds about 4,022 cases. The drugs involved are Novo Nordisk's Ozempic, Wegovy, Rybelsus, Victoza and Saxenda, and Eli Lilly's Trulicity, Mounjaro and Zepbound.

The court set a Rule 702 hearing for September 10–18, 2026. At that hearing, the judge decides whether each side's expert witnesses are reliable enough for a jury to hear. This hearing matters a lot. If key experts on the link between the drugs and these injuries are excluded, many claims can fail at once. According to the court's orders page and Drugwatch's September update, no settlement has been announced, no class has been certified, and there is no claim form.

What Is Happening in the Depo-Provera Brain Tumor Cases?

Depo-Provera MDL 3140 is in the Northern District of Florida before Judge M. Casey Rodgers. Drugwatch's September 2026 lawsuit overview reports more than 6,400 lawsuits claiming that Pfizer's birth-control shot caused meningioma, a usually noncancerous tumor that grows from the lining of the brain. The FDA approved a meningioma warning for the label in December 2025. The court calendar has a Rule 702 expert hearing on September 18, 2026.

There is also an order to get the first pilot case to trial by December 2026. A pilot trial shows both sides how juries respond to the evidence, and that often drives settlement values. One report says Pfizer agreed to a global settlement in June 2026. Until a court order or a Pfizer filing lays out the terms, treat the case as headed for trial. Anyone deciding whether to file should ask a lawyer how filing deadlines apply to their own shot history and diagnosis date.

What Do the Zantac Rulings Mean for Claimants?

Zantac cases against GSK have split into two paths. On April 13, 2026, Delaware Superior Court granted GSK summary judgment in every Zantac case filed on or before December 1, 2025. The court found that plaintiffs had not shown general causation, meaning proof that the drug can cause the cancers claimed. GSK says it now has no Zantac cases pending in Delaware.

The other path is settlement. In GSK's Form 6-K filed with the SEC, the company says it has agreements to settle about 93% of its U.S. state-court Zantac cases. That covers roughly 80,000 plaintiffs for about $2.2 billion in cash. In practice:.

If you already have a filed claim, payment comes through your lawyer under those private agreements.
There is no public claim form to look for.
About $2.2 billion across 80,000 plaintiffs averages roughly $27,500 before fees and costs. Individual amounts will vary widely.

What About Tepezza and Suboxone?

Tepezza MDL 3079 has 277 pending cases. They claim that Horizon/Amgen's thyroid eye disease drug caused permanent hearing loss. According to MDL Update's September 2026 page, bellwether trial deadlines were removed in December 2025, and no global settlement had been announced. Bellwether trials are early test trials whose results guide the rest of the cases.

Suboxone MDL 3092 in the Northern District of Ohio combines dental injury claims against the drug's maker, Indivior. These claims involve tooth decay and tooth loss linked to the film version of the drug, which dissolves in the mouth. The case is listed in the JPML's pending MDL reports. For both cases, a smaller or slower MDL is not a closed one. People with possible claims should still watch filing deadlines, which run under each state's own law.

How to Track These Cases Yourself

The Judicial Panel on Multidistrict Litigation (JPML) is the federal panel that decides which similar cases get grouped. Its September 1, 2026 list of pending MDLs is the official count of cases in each federal drug injury MDL, and the numbers change every month. A practical checklist:.

Look up the MDL number (3094, 3140, 3079, 3092) in the latest JPML report to see whether cases are growing or shrinking.
Check the court's own MDL page for orders, hearing dates and any settlement program notice.
Treat any "claim form" for these drugs with suspicion unless a court order or company filing backs it up.
Keep pharmacy records, prescription dates and medical diagnoses together. A lawyer will ask for them first.

Frequently Asked Questions

Can I join the GLP-1 or Depo-Provera litigation by filling out a form?

No. These are MDLs, not class actions, so each person files their own lawsuit, usually through a lawyer.

Do Delaware's Zantac rulings affect cases in other states?

The April 2026 summary judgment covered Delaware Superior Court cases filed on or before December 1, 2025. GSK's separate settlement deals cover about 93% of its U.S. state-court cases.

Why do case counts in these MDLs keep changing?

New lawsuits are filed and others are dismissed or settled. That is why the JPML publishes an updated count every month.

Caring for someone with dementia? Find practical guides at HelpDementia.com. Working out a skin routine? Evidence-based answers at AcneAdvocate.com. Forgot the name of a movie? Identify it at FindThisMovie.com. Was your data exposed? Track active breaches at DataBreachRadar.com.